Daniel Brennan

Work Rating Distribution Performance Price Targets & Ratings Chart

Analyst Daniel Brennan works at COWEN and is focused on Healthcare, ´╗┐Basic Materials sectors with 231 price targets and ratings documented since 2013 spanning on 18 stocks. Previously, Daniel Brennan worked at UBS, MORGAN STANLEY. Analyst's average stock valuation to be materialised ratio is 65.67% with an average time for price targets to be met of 147.37 days.

Most recent stock forecast was given on AVTR, Avantor, Inc at 14-Sep-2022.

Daniel Brennan best performing recommendations are on NVTA (INVITAE CORPORATION).
The best stock recommendation documented was for NVTA (INVITAE CORPORATION) at 7/26/2022. The price target of $2 was fulfilled within 1 day with a profit of $0.06 (3.09%) receiving and performance score of 30.93.

Average potential price target upside

Currently, out of the existing stock ratings of Daniel Brennan - 2641 which are a Buy (70.61%), 162 which are a Sell (4.33%), 937 which are a Hold (25.05%)

BRKR CRL CTLT EXAS IQV NEO SLGC TMO A AVTR ICLR ILMN MTD NVTA TX WAT DHR NSTG

Analyst name

Rating

Current price target

Potential distance

Previous price target

Date

Price targets met ratio

Average potential upside

Average time for PT to be met

Performance score

Buy

70

$-7.7 (-9.91%)

5 months 10 days ago

2/2 (100%)

$7.92 (15.45%)

46

Hold

80

$11.56 (16.89%)

85

7 months 9 days ago

10/12 (83.33%)

$1.68 (2.08%)

57

Buy

87

$9.3 (11.97%)

85

10 months 26 days ago

13/16 (81.25%)

$9.12 (18.24%)

210

Buy

86

$8.3 (10.68%)

91

1 years 1 months 17 days ago

8/10 (80%)

$4.45 (13.19%)

240

Buy

85

$7.3 (9.40%)

56

1 years 1 months 17 days ago

3/4 (75%)

$8.91 (20.44%)

372

Show more analysts
BRKR CRL CTLT EXAS IQV NEO SLGC TMO A AVTR ICLR ILMN MTD NVTA TX WAT DHR NSTG